Items where authors include "Seymour, JF"

Article

Thanarajasingam, G, Minasian, LM, Bhatnagar, V et al. (37 more authors) (2022) Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies. The Lancet Haematology, 9 (5). e374-e384. ISSN 2352-3026

Kater, AP, Seymour, JF, Hillmen, P orcid.org/0000-0001-5617-4403 et al. (12 more authors) (2019) Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study. Journal of Clinical Oncology, 34 (4). pp. 269-277. ISSN 0732-183X

Thanarajasingam, G, Minasian, LM, Baron, F et al. (37 more authors) (2018) Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. The Lancet Haematology, 5 (11). e563-e598. ISSN 2352-3026

Seymour, JF, Kipps, TJ, Eichhorst, B et al. (17 more authors) (2018) Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia. New England Journal of Medicine, 378 (12). pp. 1107-1120. ISSN 0028-4793